Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mapping
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110385 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Laguna Olmos Mariano und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology. San Pedro University Hospital, Logroño, Spain. Electronic address: Mlaguna@riojasalud.es. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Sentinel Lymph Node Biopsy, Neoplasm Recurrence, Local, Sentinel Lymph Node. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: The adoption of selective sentinel lymph node biopsy (SLNB) as a viable alternative to lymphadenectomy, along with the redefinition of nodal risk groups based on molecular classification, has significantly changed the management of early-stage, high-risk preoperative endometrial cancer. MATERIALS AND METHODS: A retrospective, multicenter study was conducted under the auspices of the Spanish Gynecologic Oncology Group to evaluate recurrence rates and oncologic outcomes in patients stratified by molecular risk. Three groups were compared: SLNB alone (G1), SLNB combined with pelvic and/or para-aortic lymphadenectomy (G2), and pelvic and/or para-aortic lymphadenectomy without SLNB (G3). The primary endpoint was recurrence rate; secondary endpoints included disease-free survival (DFS), overall survival (OS), recurrence patterns. RESULTS: A total of 221 patients from 14 centers were included, with a median follow-up of 24.4 months (IQR 17-42). Forty-four patients (19.9 %) experienced recurrence. Relapse rates were 15.4 % in G1, 15.8 % in G2, and 22.2 % in G3 (p = 0.479). DFS rates were 84.6 % in G1, 84.1 % in G2, and 77.8 % in G3 (p = 0.56). OS rates were 94.2 %, 90.9 %, and 92.6 %, respectively (p = 0.651). Among the 44 patients with documented recurrence, seven had nodal recurrences, with only two occurring in the group managed with SLNB alone. CONCLUSION: In this study, patients with early-stage, high-risk preoperative endometrial cancer-classified by molecular subgroups-showed no significant differences in relapse rates, disease-free survival, or overall survival across the three management strategies. Further prospective studies with longer follow-up are warranted to validate these preliminary findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology. San Pedro University Hospital, Logroño, Spain. Electronic address: Mlaguna@riojasalud.es.
- Department of Gynecologic Oncology. La Fe University and Polytechnic Hospital. Valencia. Spain. Assistant Clinical Professor at the University of Valencia, Spain.
- Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona. Spain.
- Department of Gynecologic Oncologic, University Insular-Materno Infantil Hospital, Las Palmas Gran Canaria, Spain.
- Department of Gynecologic Oncology, Clinico Lozano Blesa Hospital, Zaragoza, Spain.
- Department of Gynecologic Oncology, Hospital Universitario 12 de Octubre, Complutense University, Madrid, Spain.
Zitieren
APA
Mariano, L. O., Pablo, P. I., Berta, D. F., Octavio, A. S., Fernando, R. R., María de Los Reyes, O. P., Nisa, B. A., Sergi, F. G., Alberto Rafael, G. C., Josefa, M. S., Soledad, F., Joana, A. V., Kristina, A., Ignacio, A. C., Paula, A., Sara, I., & SEGO Spain-GOG Group (2025). Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mapping. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110385
Vancouver
Mariano LO, Pablo PI, Berta DF, Octavio AS, Fernando RR, María de Los Reyes OP, et al. Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mapping. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110385
BibTeX
@article{Mariano2025,
author = {Mariano, Laguna Olmos and Pablo, Padilla-Iserte and Berta, Diaz-Feijoo and Octavio, Arencibia Sánchez and Fernando, Roldan Rivas and María de Los Reyes, Oliver Pérez and Nisa, Boukichou Abdelkader and Sergi, Fernández González and Alberto Rafael, Guijarro Campillo and Josefa, Marcos-Sanmartín and Soledad, Fidalgo and Joana, Amengual Vila and Kristina, Aghababyan and Ignacio, Adiego-Calvo and Paula, Alonso and Sara, Iacoponi and SEGO Spain-GOG Group, SEGO Spain-GOG Group},
title = {Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mapping},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110385}
}
EUVIMED